NYSTATIN and CARDIAC FAILURE CONGESTIVE

325 reports of this reaction

0.5% of all NYSTATIN reports

#79 most reported adverse reaction

Overview

CARDIAC FAILURE CONGESTIVE is the #79 most commonly reported adverse reaction for NYSTATIN, manufactured by Padagis US LLC. There are 325 FDA adverse event reports linking NYSTATIN to CARDIAC FAILURE CONGESTIVE. This represents approximately 0.5% of all 59,130 adverse event reports for this drug.

NYSTATIN has an overall safety score of 82 out of 100. Patients taking NYSTATIN who experience cardiac failure congestive should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE CONGESTIVE325 of 59,130 reports

CARDIAC FAILURE CONGESTIVE is a less commonly reported adverse event for NYSTATIN, but still significant enough to appear in the safety profile.

Other Side Effects of NYSTATIN

In addition to cardiac failure congestive, the following adverse reactions have been reported for NYSTATIN:

NAUSEA — 1,964 reports
FATIGUE — 1,801 reports
DIARRHOEA — 1,788 reports
PNEUMONIA — 1,612 reports
DYSPNOEA — 1,483 reports
OFF LABEL USE — 1,376 reports
VOMITING — 1,328 reports
PAIN — 1,253 reports
DRUG INEFFECTIVE — 1,231 reports
DEATH — 1,188 reports

Other Drugs Associated with CARDIAC FAILURE CONGESTIVE

The following drugs have also been linked to cardiac failure congestive in FDA adverse event reports:

ALLOPURINOL SODIUM AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE BUMETANIDE CARVEDILOL DIGOXIN DRONEDARONE ENALAPRIL MALEATE FUROSEMIDE GLYBURIDE GLYBURIDE AND METFORMIN HYDROCHLORIDE HYDRALAZINE HYDROCHLORIDE METOLAZONE MEXILETINE HYDROCHLORIDE MILRINONE LACTATE NAPROXEN AND ESOMEPRAZOLE MAGNESIUM RANOLAZINE SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE TAFAMIDIS Trelegy

Frequently Asked Questions

Does NYSTATIN cause CARDIAC FAILURE CONGESTIVE?

CARDIAC FAILURE CONGESTIVE has been reported as an adverse event in 325 FDA reports for NYSTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE CONGESTIVE with NYSTATIN?

CARDIAC FAILURE CONGESTIVE accounts for approximately 0.5% of all adverse event reports for NYSTATIN, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE CONGESTIVE while taking NYSTATIN?

If you experience cardiac failure congestive while taking NYSTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

NYSTATIN Full Profile All Drugs Causing CARDIAC FAILURE CONGESTIVE Padagis US LLC Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.